Showing 3361-3370 of 4165 results for "".
- Ocuphire’s APX3330 for Retinal Diseases to be Presented at ARVO 2021https://modernod.com/news/ocuphires-apx3330-for-retinal-diseases-to-be-presented-at-arvo-2021/2479102/Ocuphire Pharma announced that data from preclinical studies and pharmacokinetic modeling of the company’s proprietary APX3330 drug candidate will be presented on Sunday, May 2, 2021 during the Association for Research in Vision and Ophthalmology (ARVO) virtual Annual Meeting, May 1-7, 2021.
- OneSight Partners With Anthem Blue Cross and Blue Shield Foundation to Provide Free Eye Exams and Glasses in Cincinnatihttps://modernod.com/news/onesight-partners-with-anthem-blue-cross-and-blue-shield-foundation-to-provide-free-eye-exams-and-glasses-in-cincinnati/2479049/Preventative care visits have dropped significantly over the course of the pandemic, and this is especially true in under-served communities. That’s why the Anthem Blue Cross and Blue Shield Foundation teamed up with OneSight, a leading global vision care nonprofit, to provide free eye exams and
- New Educational Resource On Importance of Eye Protection in Sports/Recreational Activititeshttps://modernod.com/news/new-educational-resource-on-importance-of-eye-protection-in-sports-recreational-activitites/2479046/The International Sports Vision Association (ISVA) and Zyloware Eyewear announced the launch of Protect. Prevent. Play., a new educational resource designed to help eye care professionals educate parents, coaches, teachers, athletic trainers and athletes of all ages and skill levels abou
- Neurolens Announces the Launch of the nMD2 Measurement Devicehttps://modernod.com/news/neurolens-announces-the-launch-of-the-nmd2-measurement-device/2479022/Neurolens has announced the launch of the neurolens Measurement Device, Gen 2 (nMD2), an objective and repeatable way to measure binocular vision, or more specifically, eye alignment. Employing over 10,000 data points per patient, the eye tracking system can identify eye misalignment as small as
- After the American Academy of Ophthalmology’s Urging, Blue Cross Blue Shield Clarifies Eylea Policyhttps://modernod.com/news/after-the-american-academy-of-ophthalmologys-urging-blue-cross-blue-shield-clarifies-eylea-policy/2478988/Blue Cross Blue Shield informed the American Academy of Ophthalmology (AAO) of their updated policy on Eylea treatment to allow for continued coverage of patients who have lost three lines of vision on an eye chart, according to an AAO news release. The American Academy of Ophthalmology ha
- AAO: Looks Like the Home Office is Here to Stay. Here’s How to Protect Your Eyeshttps://modernod.com/news/aao-looks-like-the-home-office-is-here-to-stay-heres-how-to-protect-your-eyes/2478962/As home and office space merged during the pandemic, many people said they spent more time in front of screens and suffered because of it. They complained of eye strain, headaches, and dry eye, and worried that they might be doing permanent damage to their vision. Now comes a
- New Study Links Protein Causing Alzheimer’s Disease With Common Sight Losshttps://modernod.com/news/new-study-links-protein-causing-alzheimers-disease-with-common-sight-loss/2478957/Newly published research has revealed a close link between proteins associated with Alzheimer’s disease and age-related sight loss. The findings could open the way to new treatments for patients with deteriorating vision and through this study, scientists believe they could reduce the need for us
- Over 20,000 Screened for Glaucoma in India and Nigeria Thanks to Joint Initiative, Keep Sighthttps://modernod.com/news/over-20000-screened-for-glaucoma-in-india-and-nigeria-thanks-to-joint-initiative-keep-sight/2478954/Allergan, Sightsavers, and the International Agency for the Prevention of Blindness (IAPB) launched the Keep Sight 2020 video report. The report details the results from the first year of their joint initiative, funded by Allergan, which aims to prevent glaucoma-related vision loss in un
- Survey Suggests People Living With Glaucoma at Increased Risk of Sight Loss and Blindness Due to COVID-19 Pandemichttps://modernod.com/news/survey-suggests-people-living-with-glaucoma-at-increased-risk-of-sight-loss-and-blindness-due-to-covid-19-pandemic/2478946/People with glaucoma have struggled to access their healthcare treatment during the COVID-19 pandemic, putting them at risk of vision loss and blindness, according to results of a new European survey of 2,010 adults with glaucoma, including 250 UK respondents.* The survey is part of a mult
- Breakthrough by Moran Eye Center Scientist, Colleagues Fuels New Line of Disease Researchhttps://modernod.com/news/breakthrough-by-moran-eye-center-scientist-colleagues-fuels-new-line-of-disease-research/2478830/Scientists like the John A. Moran Eye Center’s Paul S. Bernstein, MD, PhD, know a special class of lipids, or fatty acids, found in the retina of the eye and in just a few other parts of the body play an important role in maintaining vision. But it’s been difficult to study whether giving